More News

13 Feb 2007 Adeza to Be Acquired by Cytyc for $24 Per Share
13 Feb 2007 Medivir Outlicenses The Antiviral Compound MIV-160 To Guangdong Lantai Viewland Pharmaceutical CO. LTD
10 Feb 2007 Q-Med has entered into a development and commercialisation agreement regarding botulinum toxin products
10 Feb 2007 Q-Med has entered into a development and commercialisation agreement regarding botulinum toxin products
09 Feb 2007 GlaxoSmithKline and XenoPort announce agreement on late-stage compound for RLS and neuropathic pain
09 Feb 2007 Corautus Genetics and VIA Pharmaceuticals Announce Merger Agreement
09 Feb 2007 Ranbaxy Gains Final US FDA Approval For Sertraline Hydrochloride Tablets
09 Feb 2007 Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
09 Feb 2007 In-licensing of MuGard(TM) from Access Pharmaceuticals
09 Feb 2007 Advanced BioHealing Enrolls First Patient in Celaderm Pilot Venous Leg Ulcer Clinical Trial
09 Feb 2007 Advanced BioHealing Enrolls First Patient in Celaderm Pilot Venous Leg Ulcer Clinical Trial
09 Feb 2007 GlaxoSmithKline and Fabre-Kramer Pharmaceuticals enter global agreement for new treatment of major depressive disorder
09 Feb 2007 SRI International and Telik Announce Exclusive License for SRI to Develop Autoimmune and Inflammatory Disease Drug Candidate
09 Feb 2007 BioSyntech announces start of patient recruitment into BST-DermOn(TM) pivotal clinical trial
09 Feb 2007 BioSyntech announces start of patient recruitment into BST-DermOn(TM) pivotal clinical trial
08 Feb 2007 Ranbaxy Announces Global Entry Into Biosimilars With Zenotech
08 Feb 2007 Lupin Pharmaceuticals, Inc. Receives US FDA Approval For Sertraline
07 Feb 2007 ImClone Systems Opts-out of Development Agreement with UCB to Focus Resources on Proprietary, Anti-VEGFr-2 Antibody IMC-1121B
07 Feb 2007 Ranbaxy Signs A New R&D Agreement With Gsk
07 Feb 2007 Mylan Announces Final FDA Approval for Sertraline Hydrochloride Tablets
07 Feb 2007 KineMed and Bayer Healthcare AG Enter Collaboration to Discover New Therapeutic Applications for Drug Candidates
07 Feb 2007 Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
06 Feb 2007 AstraZeneca Licenses Regeneron's Velocimmune(R) Technology For Discovering Human Monoclonal Antibodies
06 Feb 2007 Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
06 Feb 2007 Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top